Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: Clinical and radiological correlation

Scandinavian Journal of Rheumatology

Volumn 36, Issue 3, 2007, Pages 211-215

  Fernandes, F A ^a   Pucinelli, M L C ^a   Da Silva, N P ^a   Feldman, D ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; BLOOD SAMPLING; BRAZIL; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HISTORY; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RADIOLOGY; RATING SCALE; RHEUMATOLOGY; VISUAL ANALOG SCALE; X RAY;

ADULT; AGED; BODY MASS INDEX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE;

EID: 34547478297     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740601154186     Document Type: Article

References (24)

1. Saxne T, Heinegard D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992;31:583-91.
2. Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Hauselmann HJ. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997;36:1151-60.
3. Salminen-Mankonen H, Saamanen AM, Jalkanen M, Vuorio E, Pirila L. Syndecan-1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis. Scand J Rheumatol 2005;34:469-74.
4. Vergunst CE, van de Sande MG, Lebre MC, Tak PP. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2005;34:415-25.
5. Oldberg A, Antonsson P, Lindblom K, Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospoidins. J Biol Chem 1992;267:22346-50.
6. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann A, Paulsson M, Rosa-Pimentel E, et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992;267:6132-6.
7. Muller G, Michel A, Altenburg E. COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus and articular cartilage. Connect Tissue Res 1998;39:233-44.
8. Lohmander LS, Saxne T, Heinegard DK. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 1994;53:8-13.
9. Bleasel JF, Poole AR, Heinegard D, Saxne T, Holderbaum D, Ionescu M, et al. Changes in serum cartilage markers levels indicate altered cartilage metabolism in families with osteoarthritis-related type II collagen gene COL2A1 mutation. Arthritis Rheum 1999;42:39-45.
10. Vilim V, Vencovsky J. Cartilage oligomeric matrix protein (COMP) is present in synovium from patients with osteoarthritis and rheumatoid arthritis. Trans Orthop Res Soc 1997;22:473.
11. Forslind K, Eberhardt K, Jonsson A, Saxne T. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 1992;31:593-8.
12. Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR. Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease by serum markers of cartilage metabolism. J Clin Invest 1995;95:1071-7.
13. Skoumal M, Kolarz G, Klingler A. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol 2003;32:156-61.
14. Sharif M, Saxne T, Shepstone L, Kirwan JR, Elson CJ, Heinegard D, et al. Relationship between serum cartilage oligomeric protein levels and disease progression in osteoarthritis of knee joint. Br J Rheumatol 1995;34:306-10.
15. Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002;10:707-13.
16. Conrozier T, Saxne T, Fan CS, Mathieu P, Tron AM, Heinegard D, et al. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis 1998;57:527-32.
17. Clark AG, Jordan JM, Vilim V, Renner JB, Dragomir AD, Luta G, et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnton County Osteoarthritis Project. Arthritis Rheum 1999;42:2356-64.
18. Jordan JM, Luta G, Stabler T, Renner JB, Dragomir AD, Vilim V, et al. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnton County Osteoarthritis Project. Arthritis Rheum 2003;48:675-81.
19. Lequesne M, Mery C, Samson M, Gerard P. Indices of severity for osteoarthritis of the hip and the knee. Validation-value in comparison with the other assessment tests. Scand J Rheumatol 1987;16(Suppl 65):85-9.
20. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
21. Kellgren JH, Lawrence JS. Radiological assesment of osteoarthritis. Ann Rheum Dis 1957;16:494-501.
22. Hart DJ, Spector TD. Kellgren & Lawrence grade 1 osteophytes in the knee - doubtful or definite? Osteoarthritis Cartilage 2003;11:149-50.
23. Dragomir AD, Kraus VB, Renner JB, Luta G, Clark A, Vilim V, et al. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. Osteoarthritis Cartilage 2002;10:687-91.
24. Altman RD. The classification of osteoarthritis. J Rheumatol 1995;22(Suppl 43):42-3.